136 related articles for article (PubMed ID: 14743872)
61. [Using Hsp70 promoter to regulate target gene expression in tumor].
Huang Q; Li C
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):198-201. PubMed ID: 11866978
[TBL] [Abstract][Full Text] [Related]
62. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
63. Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis.
Leung WN; Sun X; Mak NK; Yow CM
Photochem Photobiol; 2002 Apr; 75(4):406-11. PubMed ID: 12003131
[TBL] [Abstract][Full Text] [Related]
64. mTHPC-mediated photodynamic treatment of Lewis lung carcinoma in vitro and in vivo.
Dabkeviciene D; Stankevicius V; Grazeliene G; Markuckas A; Didziapetriene J; Kirveliene V
Medicina (Kaunas); 2010; 46(5):345-50. PubMed ID: 20679751
[TBL] [Abstract][Full Text] [Related]
65. Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy.
Zheng Y; Le V; Cheng Z; Xie S; Li H; Tian J; Liu J
Cell Stress Chaperones; 2013 Mar; 18(2):203-13. PubMed ID: 23160804
[TBL] [Abstract][Full Text] [Related]
66. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
67. Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model.
Wright KE; Liniker E; Loizidou M; Moore C; Macrobert AJ; Phillips JB
Br J Cancer; 2009 Aug; 101(4):658-65. PubMed ID: 19638975
[TBL] [Abstract][Full Text] [Related]
68. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Blant SA; Woodtli A; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
[TBL] [Abstract][Full Text] [Related]
69. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
70. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
[TBL] [Abstract][Full Text] [Related]
71. mTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha.
Dabkeviciene D; Sasnauskiene A; Leman E; Kvietkauskaite R; Daugelaviciene N; Stankevicius V; Jurgelevicius V; Juodka B; Kirveliene V
Photochem Photobiol; 2012; 88(2):432-9. PubMed ID: 22171990
[TBL] [Abstract][Full Text] [Related]
72. Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
Chang SC; Chern IF; Hsu YH
Proc Natl Sci Counc Repub China B; 1999 Oct; 23(4):158-66. PubMed ID: 10518316
[TBL] [Abstract][Full Text] [Related]
73. Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts.
Tran N; Krueger T; Pan Y; Yan H; Cheng C; Altermatt HJ; Ballini JP; Borle F; Ris HB; Andrejevic-Blant S
Lasers Surg Med; 2007 Mar; 39(3):237-44. PubMed ID: 17345623
[TBL] [Abstract][Full Text] [Related]
74. Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hyperthermia in rat tumors.
Frank J; Lambert C; Biesalski HK; Thews O; Vaupel P; Kelleher DK
Int J Cancer; 2003 Dec; 107(6):941-8. PubMed ID: 14601053
[TBL] [Abstract][Full Text] [Related]
75. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
76. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.
Castano AP; Liu Q; Hamblin MR
Br J Cancer; 2006 Feb; 94(3):391-7. PubMed ID: 16421588
[TBL] [Abstract][Full Text] [Related]
77. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
78. Arsenite-induced apoptosis is prevented by antioxidants in zebrafish liver cell line.
Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Lee HK; Lee BH; Ryu DY; Park JH
Toxicol In Vitro; 2007 Aug; 21(5):870-7. PubMed ID: 17416483
[TBL] [Abstract][Full Text] [Related]
79. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells.
Jalili A; Makowski M; Switaj T; Nowis D; Wilczynski GM; Wilczek E; Chorazy-Massalska M; Radzikowska A; Maslinski W; Biały L; Sienko J; Sieron A; Adamek M; Basak G; Mróz P; Krasnodebski IW; Jakóbisiak M; Gołab J
Clin Cancer Res; 2004 Jul; 10(13):4498-508. PubMed ID: 15240542
[TBL] [Abstract][Full Text] [Related]
80. Photodynamic Therapy Mediated by a Novel Chlorin Derivative, TONS 501-Na, in EMT6 cells.
Osaki T; Sakata I; Uto Y; Azuma K; Murahata Y; Tsuka T; Itoh N; Imagawa T; Okamoto Y
Anticancer Res; 2017 Apr; 37(4):1723-1728. PubMed ID: 28373434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
